Pig and Mouse Models of Hyperlipidemia and Atherosclerosis

• Published in: Methods in molecular biology (Clifton, N.J.) Vol. 2419; p. 379
• Main Authors: Getz, Godfrey S, Reardon, Catherine A
• Format: Journal Article
• Language: English
• Published: United States 2022
• Subjects: Animals; Atherosclerosis - pathology; Disease Models, Animal; Hypercholesterolemia - genetics; Hyperlipidemias - genetics; Lipoproteins; Mice; Swine; Lipoproteins; LDL deficiency; Diet; Mouse; apoE deficiency; Atherosclerosis; Antisense oligonucleotides; PCSK9; Coronary arteries; Pig
• ISSN: 1940-6029
• DOI: 10.1007/978-1-0716-1924-7_24

Atherosclerosis is a chronic inflammatory disorder that is the underlying cause of most cardiovascular disease. Resident cells of the artery wall and cells of the immune system participate in atherogenesis. This process is influenced by plasma lipoproteins, genetics, and the hemodynamics of the blood flow in the artery. A variety of animal models have been used to study the pathophysiology and mechanisms that contribute to atherosclerotic lesion formation. No model is ideal as each has its own advantages and limitations with respect to manipulation of the atherogenic process and modeling human atherosclerosis and lipoprotein profile. In this chapter we will discuss pig and mouse models of experimental atherosclerosis. The similarity of pig lipoprotein metabolism and the pathophysiology of the lesions in these animals with that of humans is a major advantage. While a few genetically engineered pig models have been generated, the ease of genetic manipulation in mice and the relatively short time frame for the development of atherosclerosis has made them the most extensively used model. Newer approaches to induce hypercholesterolemia in mice have been developed that do not require germline modifications. These approaches will facilitate studies on atherogenic mechanisms.